These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 2218072
1. Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Hayes BE, Clarke DE. Res Commun Chem Pathol Pharmacol; 1990 Jul; 69(1):71-83. PubMed ID: 2218072 [Abstract] [Full Text] [Related]
2. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide. Visentin V, Bour S, Boucher J, Prévot D, Valet P, Ordener C, Parini A, Carpéné C. Eur J Pharmacol; 2005 Oct 17; 522(1-3):139-46. PubMed ID: 16202994 [Abstract] [Full Text] [Related]
3. Soluble semicarbazide-sensitive amine oxidase (SSAO) activity is related to oxidative stress and subchronic inflammation in streptozotocin-induced diabetic rats. Somfai GM, Knippel B, Ruzicska E, Stadler K, Tóth M, Salacz G, Magyar K, Somogyi A. Neurochem Int; 2006 Jun 17; 48(8):746-52. PubMed ID: 16524643 [Abstract] [Full Text] [Related]
4. [Determination of serum semicarbazide-sensitive amine oxidase activity in diabetic retinopathy in type-2 diabetes]. Dura E, Mészáros Z, Salacz G, Magyar K, Romics L, Karádi I. Orv Hetil; 2002 Nov 24; 143(47):2637-44. PubMed ID: 12532650 [Abstract] [Full Text] [Related]
9. Regulation of semicarbazide-sensitive amine oxidase expression by tumor necrosis factor-alpha in adipocytes: functional consequences on glucose transport. Mercier N, Moldes M, El Hadri K, Fève B. J Pharmacol Exp Ther; 2003 Mar 31; 304(3):1197-208. PubMed ID: 12604697 [Abstract] [Full Text] [Related]
12. Developmental vasculotoxicity associated with inhibition of semicarbazide-sensitive amine oxidase. Langford SD, Trent MB, Balakumaran A, Boor PJ. Toxicol Appl Pharmacol; 1999 Mar 15; 155(3):237-44. PubMed ID: 10079209 [Abstract] [Full Text] [Related]
13. The effect of streptozotocin-induced diabetes and insulin treatment on angiotensin converting enzyme activity. Valentovic MA, Elliott CW, Ball JG. Res Commun Chem Pathol Pharmacol; 1987 Oct 15; 58(1):27-39. PubMed ID: 2829328 [Abstract] [Full Text] [Related]
14. Changes in the activities of semicarbazide-sensitive amine oxidase in inferior mesenteric artery segments and in serum of patients with type 2 diabetes. Nunes SF, Figueiredo IV, Pereira JS, Soares PJ, Caramona MM, Callingham B. Acta Diabetol; 2010 Jun 15; 47(2):179-82. PubMed ID: 20063021 [Abstract] [Full Text] [Related]
16. The interaction of hydralazine with a semicarbazide-sensitive amine oxidase in brown adipose tissue of the rat. Its use as a radioactive ligand for the enzyme. Barrand MA, Callingham BA. Biochem J; 1985 Dec 01; 232(2):415-23. PubMed ID: 4091799 [Abstract] [Full Text] [Related]
17. Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds. Eriksson M, Fowler CJ. Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct 01; 327(4):273-8. PubMed ID: 6514011 [Abstract] [Full Text] [Related]
18. Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Precious E, Gunn CE, Lyles GA. Biochem Pharmacol; 1988 Feb 15; 37(4):707-13. PubMed ID: 3342102 [Abstract] [Full Text] [Related]